Dysplasia and cancer in the dextran sulfate sodium mouse colitis model. Relevance to colitis-associated neoplasia in the human: A study of histopathology, B-catenin and p53 expression and the role of inflammation

Carcinogenesis

Volumn 21, Issue 4, 2000, Pages 757-768

  Cooper, Harry S ^a   Murthy, Sreekant ^b   Kido, Kazuaki ^b,c   Yoshitake, Hiraoki ^b,c   Flanigan, Anne ^b  

^a FOX CHASE CANCER CENTER   (United States)

^b DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^c FUKUOKA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; DEXTRAN SULFATE; PROTEIN P53;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL MEMBRANE; CELL NUCLEUS; COLITIS; COLON CANCER; CONTROLLED STUDY; CYTOPLASM; DISEASE COURSE; DYSPLASIA; FEMALE; HISTOPATHOLOGY; INFLAMMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SCORING SYSTEM; ULCERATIVE COLITIS;

EID: 0034052970     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/21.4.757     Document Type: Article

References (81)

1. Langholz, E., Munkhol, M.P., Davidsen, M and Binder, V. (1994) Course of ulcerative colitis: analysis of changes in disease activity over years. Gastroenterology, 107, 3-11.
2. Lennard-Jones, J.E., Melville, D.M., Morson, B.C., Ritchie, J.K. and Williams, C.B. (1990) Pre-cancer and cancer in extensive ulcerative colitis: findings among 401 patients over 22 years. Gut, 31, 800-806.
3. Korelitz, B.I. (1990) Consideration of surveillance, dysplasia and carcinoma of the colon in the management of ulcerutive colitis and Crohn's disease. Med. Clin. N. Am., 74, 189-199.
4. Lindberg, B., Person, B., Veress, B., Ingelman-Sundberg, H. and Grandqvist, S. (1996) Twenty years colonoscopic surveillance of patients with ulcerative colitis. Detection of dysplasia and malignant transformation. Scand. J. Gastroenterol., 31, 1195-1204.
5. Lofberg, R., Brostrom, O., Karlen, P., Tribukait, B. and Ost, A. (1990) Colonoscopic surveillance in longstanding total ulcerative colitis-a fifteen year follow up study. Gastroenterology, 99, 1021-1031.
6. Connell, W.R., Lennard-Jones, J.E., Williams, CB., Talbot, I.C., Price, A.B. and Wilkinson, K.H. (1994) Factors affecting the outcome of endoscopie surveillance for cancer and ulcerative colitis. Gastroenterology, 107, 934-944.
7. Ranshoff, D.F., Riddell, R.H. and Levin, B. (1985) Ulcerative colitis in colonic cancer. Problems in assessing the diagnostic usefulness of mucosal dysplasia. Dis. Colon Rectum, 28, 383-388.
8. Taylor, B.A., Pemberton, J.H., Carpenter, H.A., Levin, K.E., Schroeder, K.W., Welling, D.R., Spencer, M.P. and Zinsmeister, A.R. (1992) Dysplasia in chronic ulcerative colitis. Implications for colonoscopic surveillance. Dis. Rectum, 35, 950-956.
9. Rosenstock, E., Farmer, R.G., Petras, R., Sivak, M.W. Jr, Rankin, G.B. and Sullivan, B.H. (1985) Surveillance for colonic carcinoma in ulcerative colitis. Gastroenterology, 89, 1342-1346.
10. Elson, CO., Sartor, R.B., Tennyson, G.S. and Riddell, R.H. (1995) Experimental models of inflammatory bowel disease. Gastroenterology, 109, 1344-1367.
11. Johnson, R.D., Ausman, L.M., Sehgal, P.K. and King, N.W. Jr (1996) A prospective study of the epidemiology of colitis and colon cancer in cotton top tamarins (Saguinus oedipus). Gastroenterology, 110, 102-115.
12. Wood, J.D., Peck, O.C., Tefend, K.S., Rodriguez, M.A., Rodriguez, J.V., Hernandez, J.I., Stonerook, M.J. and Sharma, H.M. (1998) Colitis and colon cancer in cotton top tamarins (Saguinus oedipus oedipus). Living wild in their natural habitat. Dig. Dis. Sci., 43, 1443-1453.
13. Berg, D.J., Davidson, N., Kuhn, R., Muller, W., Mennon, S., Holland, D.G., Thompson-Snipes, L., Leach, M.W. and Rennick, D. (1995) Enterocolitis in colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD (+) TH1-like responses. J. Clin. Invest., 98, 1010-1020.
14. Rudolph, U., Finegold, M.J., Ridge, S.S., Harriman, G.R., Srinivassan, Y., Brabet, P., Goyley, G., Bradley, A. and Birnbaumer, L. (1995) Ulcerative colitis in adenocarcinoma of a colon in G alpha 1-2 deficient mice. Nature Genet., 10, 143-150.
15. Okaysau, I., Ohkusa, T., Kajiura, K., Kanno, J. and Sakamoto, S. (1996) Promotion of colorectal neoplasia in experimental murine ulcerative colitis. Gut, 39, 87-92.
16. Hirono, I., Kuhara, K., Hosaka, S., Tomizawa, S. and Goldberg, L. (1981) Induction of intestinal tumors in rats by dextran sulfate sodium. J. Natl Cancer Inst., 66, 579-583.
17. Yamada, M., Ohkusa, T. and Okayas, U. (1992) Occurrence of dysplasia in adenocarcinoma after experimental chronic ulcerative colitis in hamsters induced by dextran sulfate sodium. Gut, 33, 1521-1527.
18. Okayasu, I., Hatakeyma, S., Yamada, M., Ohkusa, T., Inagaki, Y. and Nakaya, R. (1990) A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology, 98, 694-702.
19. Cooper, H.S., Murthy, S.N.S., Shaa, R.S. and Sedergran, D.J. (1993) Clinical pathological study of dextran sulfate sodium experimental murine colitis. Lab. Invest., 69, 238-249.
20. Tamaru, T., Kobayashai, H., Kishimoto, S., Kagiyana, G., Shimamoto, F. and Brown, W.R. (1993) Histochemical study of colonic cancer in experimental colitis of rats. Dig. Dis. Sci., 38, 529-537.
21. Ishioka, T., Kuwabara, N., Ohashi, Y. and Wakabash, I.K. (1982) Induction of colorectal tumors in rats by sulfated polysacroid. SRC Crit. Rev. Toxicol., 17, 215-244.
22. Murthy, S.N., Cooper, H.S., Shim, H., Shah, R.S., Ibrahim, S.A. and Sedergran, D.J. (1993) Treatment of dextran sulfate sodium induced murine colitis by intracolonic cyclosporin. Dig. Dis. Sci., 38, 1722-1734.
23. Chaubert, P., Benhattar, J., Saraga, E. and Costa, J. (1994) K ras mutations and p53 alterations in neoplastic and non-neoplastic lesions associated with longstanding ulcerative colitis. Am. J. Pathol., 144, 767-775.
24. Kern, S.E., Redstone, M., Seymour, A.B., Caldas, C., Powell, S.M. Kornacki, S. and Kinzler, K.W. (1994) Molecular genetic profiles of colitis associated neoplasms. Gastroenterology, 107, 420-428.
25. Benhattar, J. and Saraga, E. (1995) Molecular genetics of dysplasia and ulcerative colitis. Eur. J. Cancer, 31a, 1171-1173.
26. Harpaz, N., Peck, A.L., Yin, J., Fiel, I., Hontanosas, M., Tong, T.R., Laurin, J.N., Abraham, J.M., Greenwald, B.D. and Meltzer, SJ. (1994) p53 protein expression in ulcerative colitis-associated colorectal dysplasia and carcinoma. Hum. Pathol., 25, 1069-1074.
27. Brentnall, T.A., Crispin, D.A., Rabinovitch, P.S., Haggitt, R.C., Rubin, C.E., Stevens, A.C. and Burmer, G.A. (1994) Mutations in the p53 gene: an early marker of neoplastic progression in ulcerative colitis. Gastroenterology, 107, 369-378.
28. Burmer, G.C., Crispin, D.A., Kolli, D.R., Haggitt, R.C., Kulander, B.G., Rugin, C.E. and Rabinovitch, P.S. (1991) Frequent loss of a p53 allele in carcinomas and their precursors in ulcerative colitis. Cancer Commun., 3, 167-172.
29. Yin, J., Harpez, N., Tong, Y., Wang, Y., Laurin, J., Greenwald, B.D., Hontanosas, M., Newkirk, C. and Meltzer, S.J. (1993) p53 point mutations in dysplastic and cancerous ulcerative colitis lesions. Gastroenterology. 104, 1633-1639.
30. Taylor, H.W., Boyle, M., Smith, S.C., Bustin, S. and Williams, N.S. (1993) Expression of p53 in colorectal cancer and dysplasia complicating ulcerative colitis. Br. J. Surg., 80, 442-444.
31. Ilyas, M. and Talbot, I.C. (1995) p53 expression in ulcerative colitis in longitudinal study. Gut, 37, 802-804.
32. Tomlinson, I., Ilyas, M., Johnson, V., Davies, A., Clark, G., Talbot, I. and Bodmer, W. (1998) The comparison of the genetic pathways involved in the pathogenesis of three types of colorectal cancer. J. Pathol., 184, 148-152.
33. Reaves, M., Lin, T., Masden, J. and Green, D.R. (1998) p53 protects against the development of dysplasia in dextran sulfate induced colitis. Gastroenterology, 114, A666.
34. Suzi, M., Yoshimi, N., Ushisima, T., Hirose, Y., Makita, H., Wang, A., Kawamon, T., Tanaka, T., Mori, H. and Nagao, M. (1995) No involvement of Ki-ras or p53 gene mutations in colitis associated rat colon tumors induced by 1-hydroxanthraquinone and methyazoxymethanol acetate. Mol. Carcinog., 12, 193-197.
35. Ilyas, M. and Tomlinson, I.P.M. (1997) The interactions of APC, E-cadherin and B-catenin in tumor development and progression. J. Pathol., 182, 128-137.
36. Morin, P.J., Sparks, A.P., Corinek, V., Barker, N., Cleaver, S.H., Vogelstein, B. and Kinzler, K.W. (1997) Activation of B-catenin-TCF signaling in colon cancer by mutations in B-catenin or APC. Science, 275, 1787-1790.
37. Inomata, M., Ochiai, A., Akimoto, S., Kitano, S. and Hirohashi, S. (1996) Alteration of B-catenin expression in colonic epithelial cells of familial cells adenomatous polyposis patients. Cancer Res., 56, 2213-2217.
38. Takayama, T., Shiozaki, H., Shibamoto, S., Oka, H., Kimura, Y., Tamura, S., Inoue, M., Monden, T., Ito, F. and Monden, M. (1996) B-catenin expression in human cancers. Am. J. Pathol., 148, 39-46.
39. Valizadeh, A., Karayiannakis, A.G., Elharir, I., Kimot, T.W. and Pignatelli, M. (1997) Expression of E-cadherin-associated molecules (alpha, beta and gamma catenins and p120) in colorectal polyps. Am. J. Pathol., 150, 1977-1984.
40. Hao, X., Tomlinson, I., Ilyas, M., Palazzo, W.P. and Talbot, I.C. (1997) Reciprocity between membranous and nuclear expression of B-catenin in colorectal tumors. Varchows Arch., 431, 167-172.
41. Sheng, H., Shao, J., Williams, C.S., Pereira, M.A., Taketo, M.M., Oshima, M., Reynolds, B., Washington, M.K., DuBois, R.N. and Beauchamp, R.D. (1998) Nuclear translocation of beta-catenin in hereditary and carcinogen-induced intestinal adenomas. Carcinogenesis, 19, 543-549.
42. Takahashi, N., Fukuda, K., Sugimura, T. and Wakadayashi, K. (1998) B-catenin is frequently mutated and demonstrates altered cellular localization in azoxymethane induced rat colon tumor. Cancer Res., 58, 42-46.
43. Suzi, M., Ushijima, T., Dashwood, R.H., Yoshimi, N., Ssugimura, T., Mori, H. and Minako, N. (1999) Frequent mutations of the rat B-catenin gene in colon cancers induced by methlazoxymethanol acetate plus 1-hydroxyanthraquinone. Mol. Carcinog., 24, 232-237.
44. Riddell, R.H., Goldman, H., Ransohof, D.F., Appleman, H.D., Fenoglio, C.M., Haggitt, R.C., Ahren, C. Correa, P., Hamilton, S.R., Morson, B.C., Sommers, S.C. and Yardley, J.H. (1983) Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical application. Hum. Pathol., 14, 931-968.
45. Ruggeri, B.A., Bauer, B., Zanj, S.Y. and Klein-Szanto, AJ.P. (1994) Murine squamous cell carcinoma cell lines produced by a complete carcinogenesis protocol with benzo(a)pyrene exhibit characteristic p53 mutations and absence of H-ras and cyclin D1 abnormalities. Carcinogenesis, 15, 1613-1619.
46. Mitsunaga, S.I., Zhang, S.Y., Ruggeri, B.A., Gimenez-Conti, I., Robles, A.I., Conti, C.J. and Klein-Szanto, A.J.P. (1995) Positive immunohistochemical staining of p53 and cyclin D in advanced mouse skin cancers but not in pre-cancerous lesions produced by benzo(a)pyrene. Carcinogenesis, 1629-1635.
47. Soong, R., Robbins, P.D., Dix, B.R., Grieu, F., Lim, B., Knowles, S., Williams, K.E., Turbet, G.R., Hause, A.K. and lacopatta, B.J. (1996) Concordance between p53 mutation overexpression in gene mutation in a large series of common human carcinomas. Hum. Pathol., 27, 1050-1055.
48. Lewin, K.S., Riddell, R.H. and Weinstein, W.M. (19921 Gastrointestinal Pathology and its Clinical Implications. Igakuo-Shoin, Tokyo and New York, pp. 929-956.
49. Collins, R.H. Jr, Feldman, M. and Fordtran, J.S. (1987) Colon cancer, dysplasia and surveillance in patients with ulcerative colitis. Crit. Rev. Engl. J. Med., 316, 1654-1658.
50. Connell, W.R.E., Lennard-Jones, J.E., Williams, C.B., Talbot, I.C., Price, A.B. and Wilkinson, K.H. (1994) Factors affecting the outcome of endoscopic surveillance for cancer and ulcerative colitis. Gastroenterology, 107, 934-944.
51. Ekbom, A., Helmick, C., Zak, M. and Adami, H.-O. (1990) Ulcerative colitis in colorectal cancer. Eng. J. Med., 323, 1228-1233.
52. Allen, D.C., Biggart, J.D. and Pyper, P.C. (1998) Large bowel mucosal dysplasia and carcinoma in ulcerative colitis. J. Clin. Pathol., 38, 30-43.
53. Vatn, M.H., Elgjo, K. and Bergen, A. (1984) Distribution of dysplasia in ulcerative colitis. Scand. J. Gastroenterol., 19, 893-895.
54. Bresalier, R.S. and Kim, Y.S. (1993) Malignant neoplasms of the intestine. In Sleisenger, M.H. and Fortran, J.S. (eds) Gastrointestinal Disease. 5th edn. WB Saunders, Philadelphia, pp. 1461-1463.
55. Pinczowski, D., Ekbom, A., Baron, J., Yuen, J. and Adami, H.-O. (1994) Risk factors for colorectal cancer of patients with ulcerative colitis: a case controlled study. Gastroenterology, 107, 117-120.
56. Ohshima, H. and Bartsch, H. (1994) Chronic infections in inflammatory processes as cancer risk factors. Possible role of nitric oxide in carcinogenesis. Mutat. Res., 305, 253-264.
57. Shactere, E., Beecham, E.J., Covey, J.M. et al. (1998) Activated neutrophiles induced prolonged DNA damage in neighboring cells. Carcinogenesis, 9, 2297-2304.
58. Weitberg, A.B. (1989) Effective combinations of antioxidants on phagocyte induced cystochromatin exchanges. Mutat. Res., 224, 1-4.
59. Whitzmnan, S.A. and Stossel, T.P. (1981) Mutations caused by human phagocytes. Science, 212, 546-547.
60. Dizdaroglu, M., Olinski, R., Doroshoj, H. and Akman, S.A. (1993) Modification of DNA bases in chromatin of intact target human cells by activated human polymorphonucleur leukocytes. Cancer Res., 53, 1269-1272.
61. Wei, H. and Frankel, K. (1992) Suppression of tumor promotor-induced oxidative events and DNA damage in-vivo by surcophytola: possible mechanism of antipromotion. Cancer Res., 52, 2298-2303.
62. Beckman, J.S., Beckman, T.W., Chen, J., Marshal, P.A. and Freeman, D.A. (1990) Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc. Natl Acad. Sci. USA, 87, 1620-1624.
63. Rosin, M.P., Anwar, W.A. and Ward, D.H.A. (1994) Inflammation, chromosomal instability and cancer: the Schistosomiasis model. Cancer Res., 54 (suppl.), 129S-133S.
64. Marletta, M.A. (1988) Mammalian synthesis of nitrite, nitrate, nitric oxide and N-nitrosating agents. Chem. Res. Toxicol., 1, 249-257.
65. Ames, B.N. (1998) Mutagenesis and carcinogenesis: endogenous and exogenous factors. Environ. Mol. Mutagen., 14, 66-77.
66. Wilcox, D.K., Higgins, J. and Bertrim, T.A. (1992) Colonic epithelial cell proliferation in a rat model of nongenotoxin-induced colonic neoplasia. Lab. Invest., 67, 405-411.
67. Sparks, A.B., Morin, P.J., Vogelstein, B. and Kinzler, K.W. (1998) Mutational analysis of the APC/B-catenin TCF pathway in colorectal cancer. Cancer Res., 58, 1130-1134.
68. Karayiannakis, A.J., Skarayiayrigos, K.N., Efstathiou, J., Valizadeh, A., Noda, M., Playford, R.J., Kmiot. W. and Pignatelli, M. (1998) Expression of catenins in E-cadherins during epithelial restitution in inflammatory bowel disease. J. Pathol., 185, 413-318.
69. Kobayashi, M., Watanabe, H., Ajioka, Y., Honama, T. and Asakura, H. (1996) Effective K ras mutation or morphogenesis of colorectal adenomas in early cancers: relationship to distribution of proliferating cells. Hum. Pathol., 27, 1042-1049.
70. Sparks, A.B., Morin, P.J., Vogelstein, B. and Kinzler, K.W. (1998) Mutational analysis of the APC/B-catenin/Tcf pathway in colorectal cancer. Cancer Res., 58, 1130-1134.
71. Iwao, K., Nalcamon, S., Kameyama, M., Imoaka, S., Kinoshita, M., Fukui, T., Ishiguro, S., Nakamura, Y. and Miyoshi, Y. (1998) Activation of the B-catenin gene by interstitial deletions involving exon 3 in primary colorectal cancers without adenomatous polyposis coli mutations. Cancer Res., 58, 1021-1026.
72. Greenblatt, M.S., Bennett, W.P., Hollstein, M. and Harris, C.C. (1994) Mutations in the p53 suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res., 54, 4855-4878.
73. Shivapurkar, N., Belinsky, S.A., Wolf, D.C., Tang, Z. and Alabaster, O. (1995) Absence of p53 gene mutation in rat colon carcinomas induced by azoxymethane. Cancer Lett., 96, 63-70.
74. Okamoto, M., Ohtsu, H., Miyaki, M. and Yonekawa, H. (1993) No allelic loss at the p53 focus in 1,2-dimethylhydrazine induced mouse colon tumors: PCR-SSCP analysis with sequenced tagged microsattelite primers. Carcinogenesis, 14, 1483-1486.
75. Matsumoto, K., Iwase, T., Hirono, I., Nishida, Y., Iwahori, Y., Hori, T., Asamoto, M., Takasuka, N., Kim, D.J., Ushijma, T., Nagao, M. and Tsuda, H. (1997) Demonstration of ras and p53 gene mutations in carcinomas of the forestomach and intestine and soft tissue sarcomas induced by N-methyl-N-nitroso urea in the rat. Jpn. J Cancer Res., 88, 129-136.
76. Tendler, Y., Reshef, R., Cohen, I., Barilai, M., Sasha, S.M., Rotter, V. and Shkolnik, T. (1994) Histochemical studies of progressive p53 mutations during colon carcinogenesis in Sprague-Dawley rats induced by N-methyl-N-nitroso-guanidine, or azoxymethane. Pathobiology, 62, 232-237.
77. Stopera, S.A. and Bird, R.P. (1993) Immunohistochemical demonstration of mutant p53 tumor suppressor gene product in aberrant crypt foci. Cytobios., 73, 73-88.
78. Purdie, C.A., Harrison, D.J., Peter, A., Dobbie, L., White, S., Howie, S.E.M., Salter, D.M., Bird, C.C., Wyllie, A.H., Hooper, M.L. and Clarke, A.R. (1994) Tumor incidence, spectrum and ploidy in mice with a large deletion in the p53 gene. Oncogene, 9, 603-609.
79. Harvey, M., McArthur, M.J., Montgomery, C.A., Butel, J.S., Bradley, A. and Donehower, L.A. (1993) Spontaneous and carcinogen induced tumorigenesis in p53 deficient mice. Nature Genet., 5, 225-229.
80. Jacks, T., Remmington, L., Williams, B.O., Schmitt, E.M., Halachmi, S., Bronson, R.T. and Weinberg, R.A. (1994) Tumor spectrum analysis in p53 mutant mice. Curr. Biol., 4, 1-7.
81. Clarke, A.R., Cummings, M.C. and Harrison, D.J. (1995) Interaction between murine germline mutations in p53 and APC predisposes to pancreatic neoplasia but not to increased intestinal malignancy. Oncogene, 11, 1913-1920.